Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Toradol, Toradol IM
Generic Name: Ketorolac
A nonsteroidal anti-inflammatory drug (NSAIDs) used for the short-term (not more than 5 days) relief of moderately severe pain. You usually start treatment by injection in a hospital or doctor's office then may switch to oral administration. The brand name is Toradol.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Migraine headaches | 28 | 4 |
|
|
|
||
| Pain | 20 | 7 |
|
|
|
|
|
| Kidney stone | 13 | 0 | |||||
| Fibromyalgia | 6 | 0 | |||||
| Migraine | 5 | 1 |
|
||||
| Increase effect of another treatment | 3 | 0 |
See all 54 patients currently taking Ketorolac
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Ketorolac
| Dizziness | 2 | |
|---|---|---|
| Acid reflux | 1 | |
| Abdominal pain | 1 | |
| Fainting | 1 | |
| Stomach upset | 1 | |
| Metallic taste in mouth | 1 | |
| See all 8 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Ketorolac. See all 23 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Course of treatment ended | 14 | ||
| Did not seem to work | 8 | ||
| Doctor's advice | 8 | ||
| Other | 6 | ||
| Side effects too severe | 4 | ||
| Not indicated | 4 | ||
| Expense | 1 | ||
| Change in health plan coverage | 1 |
Adherence
Taking treatment as prescribed
Adherence of Ketorolac
Always |
11 | 73% |
|
|---|---|---|---|
Usually |
3 | 20% |
|
Sometimes |
1 | 7% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Ketorolac
Very |
3 | 20% |
|
|---|---|---|---|
Somewhat |
2 | 13% |
|
A little |
2 | 13% |
|
Not at all |
8 | 53% |
|
Cost
Paid out of pocket
Cost of Ketorolac
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
3 | 43% |
|
$25-49 |
1 | 14% |
|
< $25 |
3 | 43% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 23, 2012.